Rathbones Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $741K | Hold |
23,666
| – | – | ﹤0.01% | 379 |
|
|
2025
Q1 | $794K | Hold |
23,666
| – | – | ﹤0.01% | 350 |
|
|
2024
Q4 | $928K | Hold |
23,666
| – | – | ﹤0.01% | 342 |
|
|
2024
Q3 | $932K | Hold |
23,666
| – | – | ﹤0.01% | 339 |
|
|
2024
Q2 | $923K | Hold |
23,666
| – | – | 0.01% | 335 |
|
|
2024
Q1 | $1.02M | Hold |
23,666
| – | – | 0.01% | 324 |
|
|
2023
Q4 | $1.09M | Hold |
23,666
| – | – | 0.01% | 300 |
|
|
2023
Q3 | $808K | Buy |
+23,666
| New | +$808K | 0.01% | 337 |
|